Abstract
Growing concerns about the commercialization of biomedical research and its potential to lead to biased inquiry has sparked calls for a renewed commitment to impartiality. Feminists, however, have roundly rejected the idea that objectivity requires scientists to be value-neutral or disinterested. Indeed, some feminists have argued that concerns about profit-driven would be best addressed by incorporating feminist values into scientific practices. This is thought to present feminists with a paradox: If commercial interests are problematic in research because they are partial to non-epistemic interests, then it would seem that feminist values would also be problematic on similar grounds. Here we argue that this apparent tension trades on an equivocation about the sense in which commercial values are problematically partial. We show not only that the bias paradox can be resolved by feminist theorists, but that feminist values can play important roles in addressing concerns related to bias in profit-driven research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adam, M. (2008). Promoting disinterestedness or making use of bias? In M. Carrier, D. Howard, & J. Kourany (Eds.), The challenge of the social and the pressure of practice (pp. 235–254). Pittsburgh, PA: University of Pittsburgh Press.
Anderson, E. (2004). Uses of value judgments in science: A general argument, with lessons from a case study of feminist research on divorce. Hypatia, 19(1), 1–24.
Angell, M. (2004). The truth about the drug companies: How they deceive us and what to do about it. New York: Random House.
Antony, L. (1993). Quine as feminist: The radical import of naturalized epistemology. In L. Antony & C. Witt (Eds.), A mind of one’s own (pp. 110–153). Boulder, CO: Westview.
Borgerson, K. (2011). Amending and defending critical contextual empiricism. European Journal for Philosophy of Science, 1(3), 435–449.
Bourgeois, F. T., Murthy, S., & Mandl, K. D. (2010). Outcome reporting among drug trials registered in ClinicalTrials.gov. Annals of Internal Medicine, 153(3), 158–166.
Brody, H. (2007). Hooked: Ethics, the medical profession, and the pharmaceutical industry. Lanham: Rowman & Littlefield.
Cain, D. M., & Detsky, A. S. (2008). Everyone’s a little bit biased (even physicians). Jama-Journal of the American Medical Association, 299(24), 2893–2895.
Cartwright, N. (2006). Well-ordered science: Evidence for use. Philosophy of Science, 73(5), 981–990.
Code, L. (1991). What can she know? Feminist theory and the construction of knowledge. Ithaca: Cornell University Press.
Colagiuri, R., Colagiuri, S., Yach, D., & Pramming, S. (2006). The answer to diabetes prevention: Science, surgery, service delivery, or social policy? American Journal of Public Health, 96(9), 1562–1569.
Crasnow, S. (2006). Feminist anthropology and sociology: Issues for social science. In S. Turner & M. Risjord (Eds.), Handbook of the philosophy of science (Vol. 15, pp. 827–860)., Philosophy of anthropology and sociology Amsterdam: Elsevier.
Currat, L., de Francisco, A., Al-Tuwaijri, S., Ghaffar, A., & Jupp, S. (2004). 10/90 report on health research 2003–2004. Geneva: Global Forum for Health Research.
Daniels, N. (2008). Just health: Meeting health needs fairly. Cambridge: Cambridge University Press.
de Melo-Martin, I., & Intemann, K. (2011). Feminist resources for biomedical research: Lessons from the HPV vaccines. Hypatia, 26(1), 79–101.
De Winter, J. (2012). How to make the research agenda in the health sciences less distorted. Theoria, 27, 75–93.
Douglas, H. E. (2009). Science, policy, and the value-free ideal. Pittsburgh: University of Pittsburgh Press.
Dupré, J. (2001). Human nature and the limits of science. New York: Oxford University Press.
Fausto-Sterling, A. (1992). Myths of gender: Biological theories about women and men (2nd ed.). New York, NY: BasicBooks.
Goldenberg, M. (2013). How can feminist theories of evidence assist clinical reasoning and decision-making? Social Epistemology: A Journal of Knowledge, Culture and Policy. doi:10.1080/02691728.2013.794871
Gross, B. (1994). What could a feminist science be? Monist, 77(4), 434–444.
Haack, S. (1998). Manifesto of a passionate moderate: Unfashionable essays. Chicago: University of Chicago Press.
Harding, S. G. (2004). A socially relevant philosophy of science? Resources from Standpoint Theory’s Controversiality. Hypatia, 19(1), 25–47.
Harding, S. G. (1986). The science question in feminism. Ithaca: Cornell University Press.
Harding, S. G. (2008). Sciences from below: Feminisms, postcolonialities, and modernities. Durham: Duke University Press.
Hundleby, C. (1997). Where standpoint stands now. Women & Politics, 18(3), 25–43.
Intemann, K. (2010). Sciences from below: Feminisms, postcolonialities, and modernities. Hypatia, 25(2), 464–469.
Intemann, K., & de Melo-Martin, I. (2010). Social values and scientific evidence: The case of the hpv vaccines. Biology and Philosophy, 25(2), 203–213.
Intemann, K., & de Melo-Martin, I. (2014). Addressing problems in profit-driven research: How can feminist conceptions of objectivity help? European Journal For Philosophy of Science, 4(2), 135–151.
James, M. J., Cook-Johnson, R. J., & Cleland, L. G. (2007). Selective COX-2 inhibitors, eicosanoid synthesis and clinical outcomes: A case study of system failure. Lipids, 42(9), 779–785.
Jørgensen, A. W., Hilden, J., & Gøtzsche, P. C. (2006). Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: Systematic review. BMJ, 333(7572), 782.
Katz, D., Caplan, A. L., & Merz, J. F. (2003). All gifts large and small—toward an understanding of the ethics of pharmaceutical industry gift-giving. American Journal of Bioethics, 3(3), 39–46.
Keller, E. F. (1985). Reflections on gender and science. New Haven: Yale University Press.
Khan, S. N., Mermer, M. J., Myers, E., & Sandhu, H. S. (2008). The roles of funding source, clinical trial outcome, and quality of reporting in orthopedic surgery literature. American Journal of Orthopedics, 37(12), E205–E212. discussion E212.
Kilama, W. L. (2009). The 10/90 gap in sub-saharan Africa: Resolving inequities in health research. Acta Tropica, 112(Suppl. 1), S8–S15.
Kitcher, P. (2011). Science in a democratic society. Amherst, NY: Prometheus Books.
Kourany, J. A. (2003). A philosophy of science for the twenty-first century. Philosophy of Science, 70(1), 1–14.
Kourany, J. A. (2010). Philosophy of science after feminism. Oxford: Oxford University Press.
Krimsky, S. (2003). Science in the private interest: Has the lure of profits corrupted biomedical research?. Lanham: Rowman & Littlefield.
Longino, H. E. (1990). Science as social knowledge: Values and objectivity in scientific inquiry. Princeton, NJ: Princeton University Press.
Longino, H. E. (2002). The fate of knowledge. Princeton, NJ: Princeton University Press.
Lundh, A., Sismondo, S., Lexchin, J., Busuioc, O. A., & Bero, L. (2012). Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews, 12, MR000033.
Magnusson, R. S. (2009). Rethinking global health challenges: Towards a “global compact” for reducing the burden of chronic disease. Public Health, 123(3), 265–274.
McGarity, T. O., & Wagner, W. (2008). Bending science: How special interests corrupt public health research. Cambridge, MA: Harvard University Press.
Michaels, D. (2008). Doubt is their product: How industry’s assault on science threatens your health. Oxford: Oxford University Press.
Nelson, L. H. (1990). Who knows: From Quine to a feminist empiricism. Philadelphia: Temple University Press.
Nkansah, N., Nguyen, T., Iraninezhad, H., & Bero, L. (2009). Randomized trials assessing calcium supplementation in healthy children: Relationship between industry sponsorship and study outcomes. Public Health Nutrition, 12(10), 1931–1937.
Pogge, T. W. M. (2009). The health impact fund and its justification by appeal to human rights. Journal of Social Philosophy, 40(4), 542–569.
Pogge, T. W. M. (2002). World poverty and human rights: Cosmopolitan responsibilities and reforms. Cambridge, MA: Polity.
Reiss, J., & Kitcher, P. (2009). Biomedical research, neglected diseases, and well-ordered science. Theoria, 24, 263–282.
Resnik, D. B. (2007). The price of truth: How money affects the norms of science. Oxford: Oxford University Press.
Sismondo, S. (2008). Pharmaceutical company funding and its consequences: A qualitative systematic review. Contemporary Clinical Trials, 29(2), 109–113.
Solomon, M. (2001). Social empiricism. Cambridge, MA: MIT Press.
Solomon, M. (2012). The web of valief. An assessment of feminist radical empiricism. In S. L. Crasnow & A. M. Superson (Eds.), Out from the shadows: Analytical feminist contributions to traditional philosophy (pp. 435–450). New York, NY: Oxford University Press.
Stevens, P. (2008). Diseases of poverty and the 10/90 gap. In P. Stevens (Ed.), Fighting the diseases of poverty (pp. 126–140). New Brunswick, NJ: Transaction.
Sun, X., Briel, M., Busse, J. W., You, J. J., Akl, E. A., Mejza, F., et al. (2011). The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: Systematic review. BMJ, 342, d1569.
Tricco, A. C., Tetzlaff, J., Pham, B., Brehaut, J., & Moher, D. (2009). Non-cochrane vs. Cochrane reviews were twice as likely to have positive conclusion statements: Cross-sectional study. Journal of Clinical Epidemiology, 62(4), 380–386.
Vidyasagar, D. (2006). Global notes: The 10/90 gap disparities in global health research. Journal of Perinatology, 26(1), 55–56.
WHO. (2008). The global burden of disease: 2004 update. Geneva: World Health Organization.
Woodsong, C., MacQueen, K., Amico, K. R., Friedland, B., Gafos, M., Mansoor, L., et al. (2013). Microbicide clinical trial adherence: Insights for introduction. Journal of the International AIDS Society, 16, 18505.
Wylie, A., & Nelson, L. H. (2007). Coming to terms with the values of science: Insights from feminist science studies scholarship. In H. Kincaid, J. Dupre, & A. Wylie (Eds.), Value-free science? Ideals and illusions (pp. 58–86). Oxford: Oxford University Press.
Yach, D., Hawkes, C., Gould, C. L., & Hofman, K. J. (2004). The global burden of chronic diseases: Overcoming impediments to prevention and control. JAMA, 291(21), 2616–2622.
Zycher, B., DiMasi, J., & Milne, C. (2010). Private sector contributions to pharmaceutical science: Thirty-five summary case histories. American Journal of Therapeutics, 17(1), 101–120.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Intemann, K., de Melo-Martín, I. (2016). Feminist Values, Commercial Values, and the Bias Paradox in Biomedical Research. In: Amoretti, M., Vassallo, N. (eds) Meta-Philosophical Reflection on Feminist Philosophies of Science. Boston Studies in the Philosophy and History of Science, vol 317. Springer, Cham. https://doi.org/10.1007/978-3-319-26348-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-26348-9_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26346-5
Online ISBN: 978-3-319-26348-9
eBook Packages: Religion and PhilosophyPhilosophy and Religion (R0)